9820/3	Lymphoid leukemia, NOS
		t(5;11)(q33;q13) NUMA1/PDGFRB a novel fusion
		Lymphocytic leukemia, NOS [obs]
		Lymphatic leukemis, NOS [obs]
		Subacute lymphoid leukemia [obs]
		Subacute lymphocytic leukemia [obs]
		Subacute lymphatic leukemia [obs]
		Aleukemic lymphoid leukemia [obs]
		Aleukemic lymphocytic leukemia [obs]
		Aleukemic lymphatic leukemia [obs]
		Lymphosarcoma cell leukemia [obs]
	9823/3	B-cell lymphocytic leukemia/small lymphocytic lymphoma (see also M-9670/3)
		Chronic lymphocytic leukaemia (CLL)
		del(13q) in chronic lymphocytic leukemia
		del(6q)
		der(8;17)(q10;q10)
		dic(9;12)(p13;p13) PAX5/ETV6
		i(5)(p10) in hematological malignancies
		i(3)(q10) in non-Hodgkin's lymphoma (NHL)
		t(7;14)(q35;q32.1) TRB/TCL1A::inv(14)(q11q32.1) TRA-TRD/TCL1A::t(14;14)(q11;q32.1) TRA-TRD/TCL1A
		-20 or monosomy 20
		+X solely in lymphomas
		Small lymphocytic lymphoma
		der(1)t(1;1)(p36;q11-q32) in hematopoietic malignancies
		t(2;18)(p11;q21)IGK/BCL2 and IGK/KDSR
		t(7;14)(p13;q11)
		t(10;14)(q24;q32) NFKB2/IGH
		t(11;14)(q11;q32)
		t(14;19)(q32;p13) IGH/EPOR::t(14;19)(q32;p13) IGH/BRD4 ?
		t(10;14)(q24;q11) TLX1/TRD::t(7;10)(q34;q24) TRB/HOX11
		Chronic lymphocytic leukemia, B-cell type (includes all variants of BCLL)
		Chronic lymphocytic leukemia
		Chronic lymphoid leukemia
		Chronic lymphatic leukemia
	9826/3	Burkitt cell leukemia (see also M-9687/3)
		Acute leukemia, Burkitt type [obs]
		B-ALL [obs]
		FAB L3 [obs]
		Burkitt cell leukemia
		Acute lymphoblastic leukemia, mature B-cell type
	9827/3	Adult T-cell leukemia/lymphoma (HTLV-1 positive) (includes all variants)
		Adult T-cell leukemia/lymphoma (ATLL)
		der(15)t(1;15)(q11-12;p11-13) and der(15)t(1;15)(q21-25;p10-13)
		i(9)(p10)
		t(7;14)(q35;q32.1) TRB/TCL1A::inv(14)(q11q32.1) TRA-TRD/TCL1A::t(14;14)(q11;q32.1) TRA-TRD/TCL1A
		+X solely in lymphomas
		t(4;12)(q21;p13)
		Adult T-cell lymphoma/leukemia
		Adult T-cell lymphoma
		Adult T-cell leukemia
	9831/3	T-cell large granular lymphocytic leukemia
		t(7;14)(p13;q11)
		T-cell large granular lymphocyte leukaemia
		T-cell large granular lymphocytosis
		NK-cell large granular lymphocytic leukemia
		Large granular lymphocytosis, NOS
		Chronic lymphoproliferative disorder of NK cells
	9832/3	Prolymphocytic leukemia, NOS
	9833/3	Prolymphocytic leukemia, B-cell type
		B-cell prolymphocytic leukemia (B-PLL)
		der(8;17)(q10;q10)
	9834/3	Prolymphocytic leukemia, T-cell type
		t(7;14)(q35;q32.1) TRB/TCL1A::inv(14)(q11q32.1) TRA-TRD/TCL1A::t(14;14)(q11;q32.1) TRA-TRD/TCL1A
		-20 or monosomy 20
		r(8)
		T-cell prolymphocytic leukemia (T-PLL)
		t(X;14)(q28;q11.2) TRA-TRD/MTCP1::t(X;7)(q28;q34) TRB/MTCP1
		t(10;14)(q24;q11) TLX1/TRD::t(7;10)(q34;q24) TRB/HOX11
	9835/3	Precursor cell lymphoblastic leukemia, NOS (see also M-9727/3)
		del(X)(p22p22) P2RY8/CRLF2::del(Y)(p11p11) P2RY8/CRLF2
		Precursor cell lymphoblastic leukemia, not phenotyped
		Acute lymphoblastic leukemia, NOS (see also M-9727/3)
		Acute lymphoblastic leukemia, precursorcell type
		Acute lymphoblastic leukemia-lymphoma, NOS
		Acute lymphocytic leukemia
		Acute lymphoid leukemia
		Acute lymphatic leukemia
		Lymphoblastic leukemia, NOS
		FAB Ll [obs]
		Acute lymphoblastic leukemia, L2 type, NOS
		FAB L2
	9836/3	Precursor B-cell lymphoblastic leukemia (see also M-9728/3)
		Pro-B ALL
		Common precursor B ALL
		Pre-B ALL
		Pre-pre-B ALL
		Common ALL
		c-ALL
	9837/3	Precursor T-cell lymphoblastic leukemia (see also M-9729/3)
		NUP214/ABL1 fusion gene on amplified episomes
		Biphenotypic Acute Leukaemia (BAL)
		del(11)(p12p13) LMO2
		del(13q) in ALL
		del(1p) solely
		del(6q) abnormalities in lymphoid malignancies
		del(6q)
		del(7)(p11-15) solely
		del(9p) in Acute Lymphoblastic Leukemia
		del(9q) solely
		der(9)t(1;9)(q11-12;q34)
		dic(7;12)(p10-p12;p11-p13)
		dic(9;12)(p13;p13) PAX5/ETV6
		dup(1q) in ALL
		Early T-cell precursor acute lymphoblastic leukemia
		i(6)(p10)
		i(8)(q10) in ALL
		t(7;14)(q35;q32.1) TRB/TCL1A::inv(14)(q11q32.1) TRA-TRD/TCL1A::t(14;14)(q11;q32.1) TRA-TRD/TCL1A
		Pediatric T-Cell Acute Lymphoblastic Leukemia
		t(1;2)(p36;p21) THADA/PRDM16
		t(1;5)(p32;q31) ?/TAL1
		t(1;5)(p32;q31) without TAL1 rearrangement
		t(1;7)(p34;q34) TRB/LCK
		t(1;12)(q21;p13) ETV6/ARNT
		t(1;7)(p32;q34) TRB/TAL1::t(1;14)(p32;q11) TRA/TAL1::1p32 rearrangements
		t(1;19)(q23;p13) TCF3/PBX1
		der(21)t(1;21)(q11-12;p11-13) and der(21)t(1;21)(q21-32;p11-13)
		t(2;14)(p13-16;q32) IGH/BCL11A
		t(2;21)(q11;q22)
		t(3;11)(q12;p15) NUP98/LNP1
		t(3;11)(q29;p15) NUP98/IQCG
		t(4;11)(q21;q23) KMT2A/AFF1
		t(4;11)(q21;p15) NUP98/RAP1GDS1
		t(4;11)(q23;p15) NUP98/RAP1GDS1
		t(4;21)(q31;q22) RUNX1/?
		t(5;6)(q33;q23) CEP85L/PDGFRB
		t(5;7)(q35;q21) TLX3/CDK6
		t(5;9)(q35;q34) SQSTM1/NUP214
		t(5;12)(q13;p13) ?/ETV6
		t(5;14)(q35;q11) RANBP17 (or TLX3)/TRD
		t(5;14)(q35;q11) TRD/NKX2-5
		t(5;14)(q35;q32) BCL11B/TLX3
		t(5;14)(q35;q32.2) BCL11B/TLX3 and NKX2-5
		t(5;17)(q13;q21)
		t(6;7)(q23;q34) TRB/MYB and AHI1
		t(6;11)(q27;q23) KMT2A/AFDN
		t(6;11)(q24.1;p15.5) NUP98/CCDC28A
		inv(7)(p15q34) TRB/HOXA10::t(7;7)(p15;q34) TRB/HOXA10
		t(7;9)(q34;q32) TRB/TAL2
		t(7;9)(q34;q34) TRB/NOTCH1
		t(7;12)(q34;p13) TRB/CCND2::t(12;14)(p13;q11) TRA or TRD/CCND2
		t(7;14)(p13;q11)
		t(7;14)(p15;q11) TRD/HOXA10
		t(7;14)(p15;q32)
		t(7;14)(q34;q11) TRA/TRB
		t(7;19)(q34;p13) TRB/LYL1
		t(8;9)(p22;p24) PCM1/JAK2
		t(8;12)(q13;p13) ETV6/NCOA2
		t(8;14)(q24;q11) TRA/MYC
		t(8;16)(p11;p13) KAT6A/CREBBP
		t(8;21)(q24;q22) RUNX1/TRPS1
		t(9;14)(q34;q32) EML1/ABL1
		t(9;22)(q34;q11) BCR/ABL1 in ALL
		t(X;7)(q22;q34) IRS4/TRB
		t(X;10)(p11;p12) DDX3X/MLLT10
		t(X;11)(q13;q23) KMT2A/FOXO4
		t(10;10)(p12;q21) CTNNA3/ARHGAP21
		t(10;11)(p12;q21) PICALM/MLLT10
		t(10;11)(q25;p15) NUP98/ADD3
		t(1;3)(p32;p21) TCTA/TAL1
		t(11;14)(p13;q11) TRD/LMO2::t(7;11)(q35;p13) TRB/LMO2
		t(7;11)(q34;p15) TRB/LMO1::t(11;14)(p15;q11) TRD/LMO1
		t(11;18)(p15;q12) NUP98/SETBP1
		t(11;19)(q23;p13.3) KMT2A/MLLT1
		t(12;12)(p13;q13) ETV6/BAZ2A
		t(12;13)(p12;q12-14) ETV6/CDX2
		t(14;21)(q11;q22) TRA/OLIG2
		der(17)t(17;17)(p13;q12-21)
		t(9;12)(q34;p13) ETV6/ABL1
		T-lineage acute lymphoblastic leukemia (T-ALL)
		+20 or trisomy 20 (solely)
		+4 or trisomy 4
		+7 or trisomy 7 (solely)
		+8 or trisomy 8
		+9 or trisomy 9
		9p Rearrangements in ALL
		11q23 rearrangements (KMT2A) in childhood acute lymphoblastic leukemia
		11q23 rearrangements (KMT2A) in leukaemia
		12p rearrangements (ETV6) in ALL
		15q13-15 Rearrangements
		t(10;14)(q24;q11) TLX1/TRD::t(7;10)(q34;q24) TRB/HOX11
		t(9;12)(p24;p13) ETV6/JAK2
		Pro-T ALL
		Pre-T ALL
		Cortical T ALL
		Mature T ALL
		T lymphoblastic leukemia/lymphoma